155 related articles for article (PubMed ID: 20829509)
1. The ATP-binding cassette transporter BCRP1/ABCG2 plays a pivotal role in cardiac repair after myocardial infarction via modulation of microvascular endothelial cell survival and function.
Higashikuni Y; Sainz J; Nakamura K; Takaoka M; Enomoto S; Iwata H; Sahara M; Tanaka K; Koibuchi N; Ito S; Kusuhara H; Sugiyama Y; Hirata Y; Nagai R; Sata M
Arterioscler Thromb Vasc Biol; 2010 Nov; 30(11):2128-35. PubMed ID: 20829509
[TBL] [Abstract][Full Text] [Related]
2. The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response.
Higashikuni Y; Sainz J; Nakamura K; Takaoka M; Enomoto S; Iwata H; Tanaka K; Sahara M; Hirata Y; Nagai R; Sata M
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):654-61. PubMed ID: 22116099
[TBL] [Abstract][Full Text] [Related]
3. The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin.
Merino G; Jonker JW; Wagenaar E; van Herwaarden AE; Schinkel AH
Mol Pharmacol; 2005 May; 67(5):1758-64. PubMed ID: 15709111
[TBL] [Abstract][Full Text] [Related]
4. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver.
Merino G; van Herwaarden AE; Wagenaar E; Jonker JW; Schinkel AH
Mol Pharmacol; 2005 May; 67(5):1765-71. PubMed ID: 15722455
[TBL] [Abstract][Full Text] [Related]
5. Differential inhibition of murine Bcrp1/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C.
González-Lobato L; Real R; Prieto JG; Alvarez AI; Merino G
Eur J Pharmacol; 2010 Oct; 644(1-3):41-8. PubMed ID: 20655304
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.
Durmus S; Xu N; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
Pharmacol Res; 2013 Oct; 76():9-16. PubMed ID: 23827160
[TBL] [Abstract][Full Text] [Related]
7. Role of P-glycoprotein on the brain penetration and brain pharmacodynamic activity of the MEK inhibitor cobimetinib.
Choo EF; Ly J; Chan J; Shahidi-Latham SK; Messick K; Plise E; Quiason CM; Yang L
Mol Pharm; 2014 Nov; 11(11):4199-207. PubMed ID: 25243894
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer-resistance protein (BCRP1) in the fetal mouse brain: development and glucocorticoid regulation.
Petropoulos S; Gibb W; Matthews SG
Biol Reprod; 2011 Apr; 84(4):783-9. PubMed ID: 21159928
[TBL] [Abstract][Full Text] [Related]
9. Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein.
Allen JD; Van Dort SC; Buitelaar M; van Tellingen O; Schinkel AH
Cancer Res; 2003 Mar; 63(6):1339-44. PubMed ID: 12649196
[TBL] [Abstract][Full Text] [Related]
10. ATP-binding cassette transporter G2 mediates the efflux of phototoxins on the luminal membrane of retinal capillary endothelial cells.
Asashima T; Hori S; Ohtsuki S; Tachikawa M; Watanabe M; Mukai C; Kitagaki S; Miyakoshi N; Terasaki T
Pharm Res; 2006 Jun; 23(6):1235-42. PubMed ID: 16715370
[TBL] [Abstract][Full Text] [Related]
11. Role of P-glycoprotein and breast cancer resistance protein-1 in the brain penetration and brain pharmacodynamic activity of the novel phosphatidylinositol 3-kinase inhibitor GDC-0941.
Salphati L; Lee LB; Pang J; Plise EG; Zhang X
Drug Metab Dispos; 2010 Sep; 38(9):1422-6. PubMed ID: 20522663
[TBL] [Abstract][Full Text] [Related]
12. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.
Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K
Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan.
de Vries NA; Zhao J; Kroon E; Buckle T; Beijnen JH; van Tellingen O
Clin Cancer Res; 2007 Nov; 13(21):6440-9. PubMed ID: 17975156
[TBL] [Abstract][Full Text] [Related]
14. Erythroblasts highly express the ABC transporter Bcrp1/ABCG2 but do not show the side population (SP) phenotype.
Yamamoto K; Suzu S; Yoshidomi Y; Hiyoshi M; Harada H; Okada S
Immunol Lett; 2007 Nov; 114(1):52-8. PubMed ID: 17905444
[TBL] [Abstract][Full Text] [Related]
15. The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
van Herwaarden AE; Jonker JW; Wagenaar E; Brinkhuis RF; Schellens JH; Beijnen JH; Schinkel AH
Cancer Res; 2003 Oct; 63(19):6447-52. PubMed ID: 14559835
[TBL] [Abstract][Full Text] [Related]
16. ATP-binding cassette, subfamily G (ABCG family).
Kusuhara H; Sugiyama Y
Pflugers Arch; 2007 Feb; 453(5):735-44. PubMed ID: 16983557
[TBL] [Abstract][Full Text] [Related]
17. Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporter ABCG2/BCRP1.
Shimano K; Satake M; Okaya A; Kitanaka J; Kitanaka N; Takemura M; Sakagami M; Terada N; Tsujimura T
Am J Pathol; 2003 Jul; 163(1):3-9. PubMed ID: 12819005
[TBL] [Abstract][Full Text] [Related]
18. The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients.
Breedveld P; Pluim D; Cipriani G; Wielinga P; van Tellingen O; Schinkel AH; Schellens JH
Cancer Res; 2005 Apr; 65(7):2577-82. PubMed ID: 15805252
[TBL] [Abstract][Full Text] [Related]
19. A proposal for the physiological significance of mdr1 and Bcrp1/Abcg2 gene expression in normal tissue regeneration and after cancer therapy.
Israeli D; Ziaei S; Gonin P; Garcia L
J Theor Biol; 2005 Jan; 232(1):41-5. PubMed ID: 15498591
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic cells from mice that are deficient in both Bcrp1/Abcg2 and Mdr1a/1b develop normally but are sensitized to mitoxantrone.
Zhou S; Zong Y; Lu T; Sorrentino BP
Biotechniques; 2003 Dec; 35(6):1248-52. PubMed ID: 14682060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
